KentCardio

23/10/2025

Diagnoses of type 2 diabetes in people under 40 have surged by 40% in recent years.

In the latest blog, we look at how insulin resistance and metabolic dysfunction often begin years before diagnosis occurs. We explore how advanced testing, such as insulin resistance assessments, mitochondrial function, and biological age screening, can identify risk early and pave the way to real prevention.

Discover why early intervention matters and how a targeted, functional-medicine approach can help >

If you're concerned about blood sugar, insulin, or weight gain, book a consultation to explore your metabolic health and for treatments.

06/10/2025

In his new article, Dr Konrad Grosser explores a promising breakthrough treatment for adrenal-based hypertension, a subtype of high blood pressure rooted in hormonal and adrenal dysfunction, often overlooked in standard care.

By digging deeper into endocrine, metabolic, and hormonal systems, functional screening can reveal the hidden causes behind seemingly 'ordinary' hypertension. From there, a targeted, systems biology-based plan can address root drivers rather than just masking symptoms.

Read more: https://kentcardio.com/a-breakthrough-treatment-for-adrenal-based-hypertension/

16/09/2025

With rising global temperatures, heatwaves aren’t just uncomfortable – they’re becoming a serious health risk, especially for older adults.

In our latest article, we explore how prolonged heat exposure impacts heart, metabolic, and immune systems – and why early detection through advanced screening is more important than ever. We share practical steps you can take now: optimising hydration, protecting sleep, checking blood pressure and heart health, supporting detox pathways, and using functional tests to uncover hidden risk.

Learn more here - https://kentcardio.com/rising-heatwaves-and-impact-on-aging-populations/

03/09/2025

A recent groundbreaking study from the University of Surrey has uncovered specific genetic variants that elevate the risk of both type 2 diabetes and certain cancers – including breast, colorectal, and pancreatic cancer.

Through advanced functional screening, including TruAge and TruIntelli testing, combined with Dr Konrad Grosser’s systems biology approach, you can identify AND influence your true risk profile.

Discover practical strategies for early intervention:

• Targeted metabolic and hormone testing
• Nutritional optimisation and lifestyle support
• Personalised plans for cancer prevention and metabolic health

Read the full article here - https://kentcardio.com/genetic-link-between-type-2-diabetes-and-cancer/

14/08/2025

Weight-Loss Medications and Diabetes.

GLP-1 drugs like Ozempic and Mounjaro can be a powerful starting point for improving blood sugar control, supporting weight loss, and reducing health risks.

But lasting success in managing diabetes and metabolic health needs more than medication. Dr Konrad Grosser uses a targeted, medically supervised approach – combining early intervention, metabolic reset, and sustainable lifestyle changes to optimise long-term health.

Read the full blog here - https://kentcardio.com/can-weight-loss-medications-help-with-diabetes/

07/08/2025

🧠 Are standard health checks giving you the full picture?

Many routine screenings only look at surface-level markers like cholesterol or blood pressure. While these can flag some risks, they often miss the early signs of deeper issues – like inflammation, hormonal imbalance, poor detox function, or nutrient depletion –that can silently increase your risk of heart disease, dementia, diabetes, and cancer.

At KentCardio, Dr Konrad Grosser takes a systems biology approach, using advanced diagnostics and functional testing to uncover what's really driving your health.

Learn more in the latest article here -

Standard health screenings often miss the early warning signs of disease. Stay ahead of the curve with functional testing at Kent Cardio.